ClinicalTrials.gg
CompletedNCT01690221Updated Jan 23, 2014

Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures

A Phase 3 interventional study of VEN 307 and Placebo in Chronic Anal Fissures, sponsored by Ventrus Biosciences, Inc. Completed at 103 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2014-01-23.

Sponsored by Ventrus Biosciences, Inc (part of Assembly Biosciences) · Phase 3, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
434
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 2,886 studies in Pain with a site in United States — 315 open to participants now, 393 under way, 24 of them phase 3. Pain · United States.

Enrollment
168th of 2,564
434 · median 66
Started
2012
with 138 others
Phase 3
343 of 2,886
17 open now
Registered
1,040th of 2,886
by date

Among the 2,886 studies in Pain with a site in United States, this one is the 168th largest by enrollment of the 2,564 interventional ones that give a count, is one of 139 that started in 2012, is one of 343 in phase 3, and was the 1,040th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

315 of the 2,886 studies in Pain with a site in United States are open now. Recruiting first, the newest first:

310 more — sign in →

All 315 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,886 studies in Pain with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine if the study drug, VEN307 (diltiazem hydrochloride cream) is safe and to see if it will help with treatment of pain associated with anal fissures.

Read the detailed description

Primary Objective:

To evaluate the efficacy of diltiazem hydrochloride cream on reduction of worst anal fissure (AF)-related pain associated with or following defecation when administered three times a day (TID) for 28 days.

03

Conditions studied

  • Chronic Anal Fissures

Browse trials for

Keywords

  • Anal
  • Fissure
  • Pain
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Males or females, aged ≥ 18 to ≤ 75 years.
  2. Subjects with evidence of a circumscribed fissure, with induration at the edges.
  3. Subjects with AF-related pain associated with or following defecation occurring at least 2 times a week for at least 28 days prior to signing the form (ICF).
  4. AF-related pain associated with or following defecation of at least 5 on an 11-point numerical rating score scale (NRS) at the last defecation prior to signing the ICF (0 being no pain; 10 being the worst possible pain).
  5. Average AF-related pain associated with or following defecation of at least 5 on an 11-point NRS during the last 3 days in which subject had a defecation during the 7 days prior to randomization.
  6. Any female of non-, including any female who: a) has had a hysterectomy, b) has had a bilateral oophorectomy, c) has had a bilateral tubal ligation or d) is post menopausal (demonstration of total cessation of menses for ≥ 1 year from the date of screening visit).
  7. Females of child bearing potential who agree to use at least one form of (may be a barrier method), during the full duration of the study.
  8. Able to communicate adequately with the investigator and to comply with the requirements for the entire study.
  9. Capable of using the IVRS and able to adequately communicate comprehension of the IVRS questions to the investigator.
  10. Capable of and freely willing to provide written informed consent prior to participating in the study.

Exclusion criteria

Exclusion Criteria:

  1. Unwilling to have visual or medical examination of the AF.
  2. More than 1 AF.
  3. Subjects with AF associated with or caused by other conditions, including but not limited to: drug-induced, trauma, infection, fistula-in-ano, inflammatory bowel disease, perianal sepsis or .
  4. Unwilling to stop all other concomitant topical preparations applied in and around the anus from signing of ICF through Day 29 of the study.
  5. Use of glyceryl trinitrate (GTN) ointment for 7 days (continuous or not) in the 28 days prior to signing the ICF.
  6. Unwilling to discontinue use of sitz baths for up to 4 hours after each application of product from signing of ICF to end of study.
  7. Unwilling to discontinue use of anesthetics from signing the ICF to end of study.
  8. Subfissure injection of botulinum toxin in the 3 months prior to signing the ICF.
  9. Known sensitivity to investigational product(s) or calcium channel blockers.
  10. Previous treatment with diltiazem hydrochloride cream or any other topical calcium channel blockers.
  11. Active treatment with anti-viral therapies for HIV (e.g. indinavir, nelfinivir, ritonavir).
  12. Treatment with any of the following medications within 14 days prior to signing the ICF:

    • Amitriptyline
    • Benzodiazepines
    • β-adrenoceptor antagonists (Beta-Blockers)
    • Buspirone
    • Calcium channel blockers
    • Carbamazepine
    • Cimetidine
    • Cyclosporin
    • Digoxin
    • Investigational agents
    • Lovastatin
    • Opioids
    • Pregabalin
    • Quinidine
    • Rifampin
  13. Following concomitant disease state:

    • Sick sinus syndrome except in the presence of a functioning ventricular pacemaker.
    • Second-or third-degree AV block except in the presence of a functioning ventricular pacemaker.
    • Hypotension (less than 90 mm Hg systolic).
    • Acute myocardial infarction and pulmonary congestion documented by x-ray.
    • History of bipolar disorder, psychosis, schizophrenia, mania, suicide attempt or suicidal ideation, or any other significant psychiatric illness (with the exception of intermittent anxiety) per investigator judgment.
    • History of renal disease per investigator judgment.
    • History of clinically significant Alzheimer's or Parkinson's disease per investigator judgment.
    • History of clinically significant hepatic disease per investigator judgment.
    • Current infection treated with a macrolide antibiotic.
    • Clinical evidence or history of fecal incontinence.
    • Clinical evidence or history of anal fistula.
    • Clinical evidence or history of anal abscess.
    • History of inflammatory bowel disease (e.g. Crohn's disease, Ulcerative Colitis).
    • History of any prior anal or rectal surgery including but not limited to: lateral sphincterotomy and anal stretch (with the exception of hemorrhoidal banding and laser surgery).
    • Grade 4 hemorrhoids.
    • Chronic constipation.
  14. History of radiation therapy to the pelvis.
  15. Fixed anal stenosis/fibrosis.
  16. Major organ transplant.
  17. Any clinically significant laboratory abnormalities during screening per investigator judgment.
  18. (BMI) > 40 kg/m2
  19. Malignancy within 5 years prior to randomization (with the exception of treated basal cell/squamous cell carcinoma of the skin).
  20. Any disease or prior/planned surgery that may interfere with the subject successfully completing the study.
  21. Currently using narcotic(s).
  22. Breast-feeding females.
  23. Employees, family members, or students of the investigator or clinical site.
Terms in these criteria, in plain language(8)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
434 participants (actual)

Study arms

  • Experimental
    VEN 307

    diltiazem hydrochloride 2% cream

    Drug: VEN 307

  • Placebo comparator
    Placebo

    Placebo Cream

    Drug: Placebo

Interventions

  • DrugDiltiazemStudies of DiltiazemDiltiazem pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    VEN307 applied three times a day, in and around the anus, for 28 days.

    Also known as: diltiazem hydrochloride 2% cream

  • DrugPlacebo

    Placebo cream applied three times a day, in and around the anus, for 28 days.

    Also known as: Placebo cream

06

What researchers measure

Primary outcomes

  1. Change from baseline (average NRS during the last 3 days in which subject had a defecation during the 7 day screening period) in average of worst AF-related pain associated with or following defecation for Days 22-28 (Week 4).

    Time frame: 28 days

07

Study locations

103 sites
  • The Crawford Clinic
    Anniston, Alabama 36207, United States
  • Surgical Association of Mobile
    Mobile, Alabama 36607, United States
  • University of South Alabama
    Mobile, Alabama 36617, United States
  • Montgomery Women's Health Association, PC
    Montgomery, Alabama 36117, United States
  • Mayo Clinic - Arizona
    Phoenix, Arizona 85054, United States
  • Desert Sun Clinical Research, LLC
    Tucson, Arizona 85710, United States
  • Arrowhead Regional Medical Center
    Colton, California 92324, United States
  • UC San Diego
    La Jolla, California 92093, United States
  • Alliance Research Centers
    Laguna Hills, California 92653, United States
  • Axis Clinical Trials
    Los Angeles, California 90036, United States
  • Cedars Sinai
    Los Angeles, California 90048, United States
  • Gastrointestinal Biosciences
    Los Angeles, California 90067, United States
  • University of California - Irvine Medical Center
    Orange, California 92868, United States
  • Digestive Care Associated, A Medical Corporation
    San Carlos, California 94070, United States
  • West Coast Clinical Research
    Tarzana, California 91356, United States
  • Rocky Mountain Clinical Research, LLC
    Denver, Colorado 80229, United States
  • Colorado Research Works
    Pueblo, Colorado 81008, United States
  • Rocky Mountain Clinical Research, LLC
    Thornton, Colorado 80229, United States
  • Connecticut Clinical Research Foundation CT Gastroenterology Institute At Bristol Hospital
    Bristol, Connecticut 06010, United States
  • Washington Hospital Center - MedStar Health Research Institute
    Washington, District of Columbia 20010, United States
  • Innovative Medical Research of South Florida
    Aventura, Florida 33160, United States
  • South Lake Pain Institute
    Clermont, Florida 34711, United States
  • Private Practice
    Hollywood, Florida 33021, United States
  • Akta Medika
    Miami Beach, Florida 33140, United States
  • Advance Medical Research Center
    Miami, Florida 33135, United States
  • Well Pharma Medical Research Corp.
    Miami, Florida 33143, United States
  • Gastroenterology Group of Naples, PA
    Naples, Florida 34102, United States
  • Healthcare Clinical Data, Inc.
    North Miami, Florida 33161, United States
  • Private Practice
    Pembroke Pines, Florida 33024, United States
  • Advanced Medical Research Center
    Port Orange, Florida 32127, United States
  • University of South Florida, South Campus
    Tampa, Florida 33606, United States
  • Florida Medical Clinic, P.A.
    Zephyrhills, Florida 33542, United States
  • Morehouse School of Medicine
    Atlanta, Georgia 30310, United States
  • Georgia Health Sciences University
    Augusta, Georgia 30912, United States
  • Atlanta Center for Gastroenterology
    Decatur, Georgia 30033, United States
  • Gastrointestinal Specialist of Georgia
    Marietta, Georgia 30060, United States
  • Atlanta Gastroenterology Consultants
    Suwanee, Georgia 30024, United States
  • NCH Medical Group
    Arlington Heights, Illinois 60004, United States
  • North Shore University Health System
    Evanston, Illinois 60201, United States
  • Indiana University School of Medicine
    Indianapolis, Indiana 46202, United States
  • Kendrick Regional Medical Center
    Indianapolis, Indiana 46237, United States
  • University of Iowa Hospital and Clinics
    Iowa City, Iowa 52242, United States
  • University of Louisville
    Louisville, Kentucky 40202-1622, United States
  • Delta Research Partners
    Monroe, Louisiana 71201, United States
  • Ochsner
    New Orleans, Louisiana 70121, United States
  • Investigative Clinical Research
    Annapolis, Maryland 21401, United States
  • University of Maryland Medical Center
    Baltimore, Maryland 21201, United States
  • Metropolitan Gastroenterology Group, Chevy Chase Clinical Research
    Chevy Chase, Maryland 20815, United States
  • Gastro Center of Maryland
    Columbia, Maryland 21045, United States
  • Meritus Center For Clinical Research
    Hagerstown, Maryland 21742, United States
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
  • Baystate Medical Center Department of Surgery
    Springfield, Massachusetts 01199, United States
  • Center for Digestive Health
    Troy, Michigan 48098, United States
  • CRC of Jackson
    Jackson, Mississippi 39202, United States
  • Jefferson City Medical Group
    Jefferson City, Missouri 65109, United States
  • Midwest Center for Clinical Research
    Lee's Summit, Missouri 64064, United States
  • Colon and Rectal Surgery, Inc
    Omaha, Nebraska 68114, United States
  • Impact Clinical Trials
    Las Vegas, Nevada 89106, United States
  • Gastroenterology Group & Endoscopy Center of South NJ (GGSJ)
    Vineland, New Jersey 08360-7072, United States
  • C&R Surgical Assoc of South Jersey
    Voorhees, New Jersey 08043-9544, United States
  • Life Medi-Research and Management
    Brooklyn, New York 11206, United States
  • HCCA Clinical Research Solutions
    New York, New York 10016, United States
  • Manhattan Surgical Associates, LLP
    New York, New York 10021, United States
  • Colorectal Associates of NY
    New York, New York 10022, United States
  • Medical Research Associates of New York (New York Gastroenterology Associates, LLP)
    New York, New York 10075, United States
  • Premier Medical Group
    Poughkeepsie, New York 12601, United States
  • Medispect
    Boone, North Carolina 28607, United States
  • Duke University
    Durham, North Carolina 27710, United States
  • Womack Army Medical Center
    Ft. Bragg, North Carolina 28310-7301, United States
  • University of North Carolina
    Raleigh, North Carolina 27599, United States
  • Wake Research Associates
    Raleigh, North Carolina 27612, United States
  • Trial Management Associates
    Wilmington, North Carolina 28403, United States
  • University Hospitals Case Medical Center
    Cleveland, Ohio 44106, United States
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
  • Dayton Gastroenterology, Inc.
    Dayton, Ohio 45415, United States
  • Great Lakes Gastroenterology
    Mentor, Ohio 44060, United States
  • Institute of Pain Research
    Oklahoma City, Oklahoma 73104, United States
  • Bend Memorial Clinic
    Bend, Oregon 97701, United States
  • The Corvallis Clinic, Clinical Research Center
    Corvallis, Oregon 97330, United States
  • Westover Heights Clinic
    Portland, Oregon 97210, United States
  • Penn State Hershey Medical Center
    Hershey, Pennsylvania 17033, United States
  • West Penn Allegheny Health System
    Monroeville, Pennsylvania 15146, United States
  • Thomas Jefferson University Hospital
    Philadelphia, Pennsylvania 19017, United States
  • Drexel Univ College of Medicine
    Philadelphia, Pennsylvania 19102, United States
  • Temple University Physicians, Jeanes Hospital
    Philadelphia, Pennsylvania 19111, United States
  • Pain Specialists of Charleston
    North Charleston, South Carolina 29406, United States
  • Gastroenterology Associates of Orangeburg, PA
    Orangeburg, South Carolina 29118, United States
  • HCCA Clinical Research Solutions
    Jackson, Tennessee 38305, United States
  • Vanderbilt Univ Dept of Colon and Rectal Surgery
    Nashville, Tennessee 37232, United States
  • Research Across America
    Dallas, Texas 75010, United States
  • Research Concepts, GP LLC
    Houston, Texas 77024, United States
  • University of TX Affiliated Hospitals
    Houston, Texas 77030, United States
  • Houston Endoscopy and Research Center
    Houston, Texas 77079, United States
  • Houston Digestive Disease Clinic
    Houston, Texas 77090-3408, United States
  • ColoProctology Associates
    Seabrook, Texas 77586, United States
  • University of Utah HSC
    Salt Lake City, Utah 84132, United States
  • Charlottesville Medical Research
    Charlottesville, Virginia 22911, United States
  • Gastroenterology Associates of Tidewater
    Chesapeake, Virginia 23320, United States
  • Jefferson Surgical Clinic
    Roanoke, Virginia 24016, United States
  • NW Gastroenterology
    Bellevue, Washington 98004, United States

Showing the first 100 of 103 sites. Choose a country and city above to see the rest.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2012, a primary completion of Dec 2013 and a completion of Jan 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2012
First posted
Sep 21, 2012
Start
Oct 2012
Primary completionActual
Dec 2013
CompletionActual
Jan 2014
Last update
Jan 23, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01690221
Responsible party
Sponsor
First posted
Sep 21, 2012
Start date
Oct 2012
Primary completion
Dec 2013
Completion
Jan 2014
Last update
Jan 23, 2014

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Diltiazem

Start the discussion